1.Clinical Trial on the Hypotensive Effect of Arotinolol(S-596) in Essential Hypertension.
Chung S LEE ; Jung E KIM ; Hyun C JANG ; Sung K PARK ; Sung K KANG
Korean Circulation Journal 1989;19(2):325-331
Arotinolol was administered orally to 31 patients to evaluate is antihypertensive action. After one week of antihypertensive medication, they were given Arotinolol 30mg daily for 4 week. Routine serum chemistries, electrolytes, urinalysis and electrocardiography were studied before and after Arotinolol. Blood pressure measured in sitting, supine and standing position was 175.3+/-5.4/115.7+/-4.0, 168.0+/-5.2/150.0+/-3.8, 154.4+/-8.5/103.4+/-3.2mmHg in control and 143.8+/-2.8/93.3+/-2.8, 144.6+/-5.4/88.1+/-4.3, 139.7+/-4.6/86.8+/-3.4mmHg in Arotinolol treatment group. The differences between both blood pressure were statistically significant(P<0.01). No laboratory test showed significant difference between both period. There were no significant side effects except 2 cases of transient headache and dizziness respectively, and one case of diarrhea. In summary, Arotinolol apears to reduce blood pressure effectively with minimal side effects.
Blood Pressure
;
Diarrhea
;
Dizziness
;
Electrocardiography
;
Electrolytes
;
Headache
;
Humans
;
Hypertension*
;
Urinalysis
2.Synchronous Gastric Adenocarcinoma and Perigastric Lymph Node Metastatic Squamous Cell Carcinoma with Unknown Primary: A Case Report
Bernard K SESHIE ; Ki Hyun KIM ; Hyun Jung LEE ; Si Hak LEE ; Sun-Hwi HWANG
Journal of Minimally Invasive Surgery 2020;23(2):99-102
We report a case of 65 years old man who was found on routine esophagogastroduodenoscopy to have gastric tumour. Histology revealed adenocarcinoma. Staging investigation with abdominal computed tomography (CT) confirmed gastric cancer of the antrum with lymph node enlargement at hepatoduodenal ligament. The patient underwent laparoscopic assisted distal gastrectomy with D2 lymphadenectomy. Pathology revealed intestinal type moderately differentiated tubular adenocarcinoma invading lamina propria (pT1a). Four positive lymph nodes out of 34 did not show metastatic adenocarcinoma but rather Squamous Cell Carcinoma (SCC) and were positive for p63 and CK5/6 on immunohistochemistary. Primary site of SCC was not found. He received adjuvant chemotherapy with TS-1 60 mg. After two years of follow-up he is asymptomatic and repeated EGD and abdominal CT Scan were normal. Herein, the authors report the case of early gastric cancer with synchronous metastatic SCC with unknown primary site.
3.CORRIGENDUM: Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
Michael ADISASMITA ; Hyomin K LEE ; Yohan AN ; Myounghoi KIM ; Michael Girma MAMO ; Junho K. HUR ; Dongho CHOI ; Ji Hyun SHIN ; Yun Kyung JUNG
Annals of Surgical Treatment and Research 2024;106(6):370-370
4.Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
Michael ADISASMITA ; Hyomin K LEE ; Yohan AN ; Myounghoi KIM ; Michael Girma MAMO ; Junho K. HUR ; Dongho CHOI ; Ji Hyun SHIN ; Yun Kyung JUNG
Annals of Surgical Treatment and Research 2024;106(5):274-283
Purpose:
One of the novel cell sources of cell-based liver regenerative medicine is human chemically-derived hepatic progenitors (hCdHs). We previously established this cell by direct hepatocyte reprogramming with a combination of small molecules (hepatocyte growth factor, A83-01, CHIR99021). However, there have been several issues concerning the cell’s stability and maintenance, namely the occurrences of epithelial-mesenchymal transition (EMT) that develop fibrotic phenotypes, resulting in the loss of hepatic progenitor characteristics. These hepatic progenitor attributes are thought to be regulated by SOX9, a transcription factor essential for hepatic progenitor cells and cholangiocytes.
Methods:
To suppress the fibrotic phenotype and improve our long-term hCdHs culture technology, we utilized the epigenetic modulating drugs DNA methyltransferase inhibitor (5-azacytidine) and histone deacetylase inhibitor (sodium butyrate) that have been reported to suppress and revert hepatic fibrosis. To confirm the essential role of SOX9 to our cell, we used clustered regularly interspaced short palindromic repeats-interference (CRISPRi) to repress the SOX9 expression.
Results:
The treatment of only 5-azacytidine significantly reduces the fibrosis/mesenchymal marker and EMT-related transcription factor expression level in the early passages. Interestingly, this treatment also increased the hepatic progenitor markers expression, even during the reprogramming phase. Then, we confirmed the essential role of SOX9 by repressing the SOX9 expression with CRISPRi which resulted in the downregulation of several essential hepatic progenitor cell markers.
Conclusion
These results highlight the capacity of 5-azacytidine to inhibit EMT-driven hepatic fibrosis and the significance of SOX9 on hepatic progenitor cell stemness properties.
5.The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
Sang Ryol RYU ; Sue K PARK ; Ji Yong JUNG ; Yeong Hoon KIM ; Yun Kyu OH ; Tae Hyun YOO ; Suah SUNG
Journal of Korean Medical Science 2017;32(2):249-256
Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence of anemia, its association with clinical and laboratory factors, and utilization of iron agents and erythropoiesis stimulating agents using the baseline data from the large-scale CKD cohort in Korea. We defined anemia when hemoglobin level was lower than 13.0 g/dL in males and 12.0 g/dL in females, or received by erythropoiesis stimulating agents. Overall prevalence of anemia was 45.0% among 2,198 non-dialysis CKD patients from stage 1 to 5. Diabetic nephropathy (DN) as a cause, CKD stages, body mass index (BMI), smoking, leukocyte count, serum albumin, iron markers, calcium, and phosphorus concentration were identified as independent risk factors for anemia. Considering the current coverage of Korean National Health Insurance System, only 7.9% among applicable patients were managed by intravenous iron agents, and 42.7% were managed by erythropoiesis stimulating agents.
Anemia*
;
Body Mass Index
;
Calcium
;
Cohort Studies*
;
Diabetic Nephropathies
;
Female
;
Hematinics
;
Humans
;
Iron
;
Korea
;
Leukocyte Count
;
Male
;
National Health Programs
;
Phosphorus
;
Prevalence*
;
Renal Insufficiency, Chronic*
;
Risk Factors
;
Serum Albumin
;
Smoke
;
Smoking
6.Healing of Bony Labyrinth after Transection and Occlusion of Lateral Semicircular Canal.
Boo Hyun NAM ; Jong Ho YANG ; Chan Il PARK ; T K JUNG
Korean Journal of Otolaryngology - Head and Neck Surgery 2000;43(6):593-597
BACKGROUND AND OBJECTIVES: Occlusion of semicircular canal has been used for otoneurologic and skull base surgery with preservation of postoperative hearing. However, research on healing process of the occluded bony semicircular canal is scarce. MATERIALS AND METHODS: We transected and occluded the lateral semicircular canal of guinea pigs using a surgical drill. Histopathologic changes of the temporal bones were observed up to the eighth postoperative week. RESULTS: The temporal bone specimens showed that ostcogenic cells proliferated from the perilymphatic fibrous mesh formed a new bone in the occluded portion of the lateral semicircular canal. Periosteal cells of the endosteum produced a compact bone layer lining the bony semicircular canal lumen. Periosteal layer produced a woven bone at the surgical defect of the lateral semicircular canal. CONCLUSION: This study shows that the perilymphatic fibrous mesh, the endosteum and the periosteal layer participated in osteogenesis in healing of the bony lateral semicircular canal after transection and occlusion.
Animals
;
Ear, Inner*
;
Guinea Pigs
;
Hearing
;
Osteogenesis
;
Semicircular Canals*
;
Skull Base
;
Temporal Bone
7.Interrupting Effect of Social Distancing on Ischemic Heart Disease, Asthma, Stroke, and Suicide Attempt Patients by PM 2.5 Exposure
Minseo CHOI ; Mia SON ; Sanghyuk BAE ; Whanhee LEE ; Kyung-Nam KIM ; Jung K HYUN
Yonsei Medical Journal 2024;65(5):302-313
Purpose:
This study aimed to examine the interrupting effect of social distancing (SD) on emergency department (ED) patients with ischemic heart disease (IHD), stroke, asthma, and suicide attempts by PM 2.5 exposure in eight Korean megacities from 2017 to 2020.
Materials and Methods:
The study used National Emergency Department Information System and AirKorea data. A total of 469014 patients visited EDs from 2017 to 2020. Interrupted time series analysis was employed to examine changes in the level and slope of the time series, relative risk, and confidence intervals (CIs) by PM 2.5 exposure. The SD level was added to the sensitivity analysis.
Results:
The interrupted time series analysis demonstrated a significant increase in the ratio of relative risk (RRR) of IHD patients in Seoul (RRR=1.004, 95% CI: 1.001, 1.006) and Busan (RRR=1.007, 95% CI: 1.002, 1.012) post-SD. Regarding stroke, only patients in Seoul exhibited a significant decrease post-SD (RRR=0.995, 95% CI: 0.991, 0.999). No significant changes were observed for asthma in any of the cities. In the case of suicide attempts, Ulsan demonstrated substantial pre-SD (RR=0.827, 95% CI: 0.732, 0.935) and post-SD (RRR=1.200, 95% CI: 1.057, 1.362) differences.
Conclusion
While the interrupting effect of SD was not as pronounced as anticipated, this study did validate the effectiveness of SD in modifying health behaviors and minimizing avoidable visits to EDs in addition to curtailing the occurrence of infectious diseases.
8.Development of Algorithm for Patient Specific Rehabilitation of Acute Stroke Patient.
Min Su KIM ; Suk Hoon OHN ; Hyun Jung CHANG ; Hyun Gun HA ; Peter K W LEE ; Yun Hee KIM
Brain & Neurorehabilitation 2009;2(2):118-133
OBJECTIVE: Team approach for patient-specific rehabilitation for acute stroke patient is important to minimize loss of function and facilitate recovery as well as cost effectiveness. We tried to establish acute stroke rehabilitation algorithm to maximize efficiency of delivering patient-specific and comprehensive rehabilitation in acute stroke patients. METHOD: We developed the clinical algorithms through the informal consensus development process by thorough discussions within the rehabilitation team members. Before and after adoption of the rehabilitation algorithms in clinical activity, we investigated satisfaction of patients and staffs by questionnaire. In addition, length of hospitalization was assessed. RESULTS: Ten algorithms were developed on the general rehabilitation, physical, occupational, and speech therapy, dysphagia, cognitive rehabilitation, nursing care and complication, and psychosocial rehabilitation. Every algorithm was comprised to take care of patients from the acute stage of rehabilitation to long term management. After algorithms to the clinical practice, total mean score of satisfaction was significantly improved in patients and staffs (p<0.05). Mean length of stay for rehabilitation tended to decline without statistical significance. CONCLUSION: Algorithm for patient specific acute stroke rehabilitation could contribute to increase the level of satisfaction among patients and staffs.
9.Focal Hepatic Lesions: Evaluation with Contrast-Enhanced Gray-Scale Harmonic US.
Hyun Jung JANG ; Hyo K LIM ; Won Jae LEE ; Seong Hyun KIM ; Min Ju KIM ; Dongil CHOI ; Soon Jin LEE ; Jae Hoon LIM
Korean Journal of Radiology 2003;4(2):91-100
OBJECTIVE: To determine the findings of various focal hepatic lesions at contrast-enhanced gray-scale ultrasound (US) using a coded harmonic angio (CHA) technique and emphasizing lesion characterization. MATERIALS AND METHODS: The study involved 95 patients with 105 focal hepatic lesions, namely 51 hepatocellular carcinomas (HCCs), 22 metastases, 22 hemangiomas, four cases of focal nodular hyperplasia (FNH), and six nontumorous nodules. After the injection of a microbubble contrast agent (SH U 508A), gray-scale harmonic US studies using a CHA technique were performed with a combination of continuous scanning to assess the intratumoral vasculature (vascular imaging) and interval-delay scanning to determine the sequential enhancement pattern (acoustic emission imaging). Each imaging pattern was categorized and analyzed. RESULTS: At vascular imaging, 69% of HCCs (35/51) showed irregular branching vessels, while in 91% of metastases (20/22) a peripherally stippled pattern was observed. Intratumoral vessels were absent in 95% of hemangiomas (21/22) and all nontumorous lesions (6/6), while in 75% of FNHs (3/4) a spoke-wheel pattern was evident. At acoustic emission imaging, 71% of HCCs (36/51) showed heterogeneous enhancement and 86% (19/22) of metastases showed rim- or flame-like peripheral enhancement during the early phase, with washout occurring in all HCCs and metastases (100%, 73/73) during the late phase. In hemangiomas, enhancement was either peripheral and nodular (19/22, 86%) or persistent and homogeneous (3/22, 14%), and 75% of FNHs (3/4) became isoechoic during the late phase. CONCLUSION: At contrast-enhanced gray-scale US using a CHA technique, a period of continuous scanning depicted the intratumoral vasculature, and interval-delay scanning demonstrated the sequential enhancement pattern. The characteristic findings of various focal hepatic lesions were thus determined.
10.Effects of Robot-assisted Gait Therapy on Locomotor Recovery in Stroke Patients.
Kyung Hoon JUNG ; Hyun Geun HA ; Hee Joon SHIN ; Suk Hoon OHN ; Duk Hyun SUNG ; Peter K W LEE ; Yun Hee KIM
Journal of the Korean Academy of Rehabilitation Medicine 2008;32(3):258-266
OBJECTIVE: To investigate the effects of robot-assisted gait therapy on locomotor recovery in hemiparetic patients after stroke. METHOD: Twenty five stroke patients were randomly divided into 2 groups. Robotic training group received 30 minutes of robot-assisted gait therapy, 3 times a week for 4 weeks, while control group received conventional gait training with same duration and frequency as robotic group. Outcome was measured using Motricity index, Fugl-Meyer assessment (FMA), function ambulation category, modified motor assessment scale, 10-meter gait speed, isometric torque, Ashworth scale, gait analysis, body tissue composition, and Beck's depression inventory (BDI). RESULTS: Robotic training group showed significant improvement in motor functions measured by Motricity Index, FMA, 10-meter gait speed, isometric torque of hip compared with the baseline and with those of control group. Ashworth scale of hip, BDI, and muscle mass showed significantly greater improvement in robotic training group than control group. In gait analysis, stride length of unaffected leg demonstrated significant improvement in robotic training group (p<0.05). CONCLUSION: The robot-assisted gait therapy with body weight-support is considered to facilitate locomotor recovery of the hemiparetic stroke patient.
Depression
;
Gait
;
Hip
;
Humans
;
Leg
;
Muscles
;
Stroke
;
Torque
;
Walking